Find trials
Search tips

Evaluation of Sensibility with Targeted Nipple Areola Complex Re-innervation in Nipple Sparing Mastectomy

Overview

About this study

To determine the effectiveness of targeted nipple areola complex (NAC) re-innervation for improving sensibility in women undergoing nipple sparing mastectomy (NSM). 

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Women ≥ 18 years of age.
  • Women who have undergone nipple sparing mastectomy (NSM) with targeted nipple areola complex (NAC) re-innervation and alloplastic reconstruction at Mayo Clinic. 

 Exclusion Criteria: 

  • < 18 years of age.

 

 

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Scottsdale/Phoenix, Ariz.

Mayo Clinic principal investigator

Alanna Rebecca, M.D.

Closed-enrolling by invitation

What is this? (?)
"Close"
Not open to everyone who meets the eligibility criteria, but only those invited to participate by the study team.

Contact information:

Jessica Gayton

(480) 574-2428

Gayton.Jessica@mayo.edu

More information

Publications

Publications are currently not available

More about research at Mayo Clinic

.
CLS-20572960

Mayo Clinic Footer